MLYS Cash Ratio
7.16TTM
Retrieved:
MLYS FY Cash Ratio
11.440.00
2020-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
MLYS cash ratio history
Cash divided by current liabilities. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.
| Period ending | Cash Ratio |
|---|---|
| 11.4419 | |
| 7.7899 | |
| 4.7037 | |
| 10.8716 | |
| 2.0997 | |
| 0.2772 |
Compare cash ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) cash ratio
- Bridgebio Pharma Inc (BBIO) cash ratio
- Brightspring Health Services Inc (BTSG) cash ratio
- Madrigal Pharmaceuticals Inc (MDGL) cash ratio
- Ensign Group Inc (ENSG) cash ratio
- Glaukos Corp (GKOS) cash ratio
- Vaxcyte Inc (PCVX) cash ratio
- Krystal Biotech Inc (KRYS) cash ratio
Compare all covered stocks by cash ratio →
All MLYS financial metrics · MLYS stock overview · How to interpret financial metrics
